222 related articles for article (PubMed ID: 24019584)
1. Contributions to the field of neurotransmitters by Japanese scientists, and reflections on my own research.
Otsuka M
Proc Jpn Acad Ser B Phys Biol Sci; 2007 Mar; 83(2):47-64. PubMed ID: 24019584
[TBL] [Abstract][Full Text] [Related]
2. Insight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinson's Disease and Huntington's Disease: A Review.
Jamwal S; Kumar P
Curr Neuropharmacol; 2019; 17(2):165-175. PubMed ID: 29512464
[TBL] [Abstract][Full Text] [Related]
3. Prenatal and postnatal contents of amino acid neurotransmitters in mouse parietal cortex.
Benítez-Diaz P; Miranda-Contreras L; Mendoza-Briceño RV; Peña-Contreras Z; Palacios-Prü E
Dev Neurosci; 2003; 25(5):366-74. PubMed ID: 14614264
[TBL] [Abstract][Full Text] [Related]
4. Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics.
Yadav D; Kumar P
Neurochem Int; 2022 Jun; 156():105327. PubMed ID: 35331828
[TBL] [Abstract][Full Text] [Related]
5. Appearance of putative amino acid neurotransmitters during differentiation of neurons in embryonic turtle cerebral cortex.
Blanton MG; Kriegstein AR
J Comp Neurol; 1991 Aug; 310(4):571-92. PubMed ID: 1682348
[TBL] [Abstract][Full Text] [Related]
6. The L-DOPA story revisited. Further surprises to be expected?
Foley P
J Neural Transm Suppl; 2000; (60):1-20. PubMed ID: 11205132
[TBL] [Abstract][Full Text] [Related]
7. The GAD-given Right of Dentate Gyrus Granule Cells to Become GABAergic.
Mody I
Epilepsy Curr; 2002 Sep; 2(5):143-145. PubMed ID: 15309121
[TBL] [Abstract][Full Text] [Related]
8. Chapter 33: the history of movement disorders.
Lanska DJ
Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
[TBL] [Abstract][Full Text] [Related]
9. Basal and Evoked Neurotransmitter Levels in Parkin, DJ-1, PINK1 and LRRK2 Knockout Rat Striatum.
Creed RB; Menalled L; Casey B; Dave KD; Janssens HB; Veinbergs I; van der Hart M; Rassoulpour A; Goldberg MS
Neuroscience; 2019 Jun; 409():169-179. PubMed ID: 31029729
[TBL] [Abstract][Full Text] [Related]
10. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
Dobrić I
Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
[TBL] [Abstract][Full Text] [Related]
11. Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr.
Lees AJ; Tolosa E; Olanow CW
Mov Disord; 2015 Jan; 30(1):19-36. PubMed ID: 25488030
[TBL] [Abstract][Full Text] [Related]
12. Neurotransmitters in the human and nonhuman primate basal ganglia.
Haber SN
Hum Neurobiol; 1986; 5(3):159-68. PubMed ID: 2876974
[TBL] [Abstract][Full Text] [Related]
13. K+-evoked release of met-enkephalin from rat striatum in vitro: effect of putative neurotransmitters and morphine.
Osborne H; Herz A
Naunyn Schmiedebergs Arch Pharmacol; 1980 Jan; 310(3):203-9. PubMed ID: 6103516
[TBL] [Abstract][Full Text] [Related]
14. Axonal transport of [3H] GABA and [3H] glutamate in excitatory and inhibitory neurons innervating lobster exoskeletal musculature.
Woodward WR
J Neurobiol; 1984 Jan; 15(1):49-65. PubMed ID: 6199461
[TBL] [Abstract][Full Text] [Related]
15. Modulation of amino acid neurotransmitter actions by other neurotransmitters: some examples.
Marshall KC; Xiong HG
Can J Physiol Pharmacol; 1991 Jul; 69(7):1115-22. PubMed ID: 1683265
[TBL] [Abstract][Full Text] [Related]
16. Scope and limitations of in vivo brain dialysis: a comparison of its application to various neurotransmitter systems.
Westerink BH; Damsma G; Rollema H; De Vries JB; Horn AS
Life Sci; 1987 Oct; 41(15):1763-76. PubMed ID: 2889121
[TBL] [Abstract][Full Text] [Related]
17. L-DOPA in Parkinson's Disease: Looking at the "False" Neurotransmitters and Their Meaning.
Chagraoui A; Boulain M; Juvin L; Anouar Y; Barrière G; Deurwaerdère P
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906250
[No Abstract] [Full Text] [Related]
18. Both ethanol and ifenprodil inhibit NMDA-evoked release of various neurotransmitters at different, yet proportional potency: potential relation to NMDA receptor subunit composition.
Fink K; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):312-9. PubMed ID: 8878061
[TBL] [Abstract][Full Text] [Related]
19. Changes in the status of neurotransmitter receptors in a rabbit model of hepatic encephalopathy.
Ferenci P; Pappas SC; Munson PJ; Henson K; Jones EA
Hepatology; 1984; 4(2):186-91. PubMed ID: 6323295
[TBL] [Abstract][Full Text] [Related]
20. Comparative quantitative aspects of putative neurotransmitters in the central nervous system of spiders (Arachnida: Araneida).
Meyer W; Schlesinger C; Poehling HM; Ruge W
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1984; 78(2):357-62. PubMed ID: 6149080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
